Items tagged with Prevention
Common contraceptive could raise TB risk (post)
A breakthrough study conducted by Professor Keertan Dheda and Dr Michele Tomasicchio, at the University of Cape Town’s (UCT) Centre for Lung Infection and Immunity, has revealed that one of South Africa’s most commonly-used injectable contraceptives could potentially increase women’s chances of contracting tuberculosis (TB).
The TB in the air we breathe (post)
Wedged between mountain and sea on a breathtaking stretch of Cape Peninsula coast, the township of Masiphumelele is home to 23 000 people on about 40 hectares of land.* Despite its name which means ‘we shall succeed’ in isiXhosa, living conditions here are dire. It is overcrowded, sanitation is not what it should be, and infectious diseases like HIV and tuberculosis (TB) are rife.
NIH launches large TB prevention trial for people exposed to multidrug-resistant TB (post)
A large clinical trial to assess treatments for preventing people at high risk from developing multidrug-resistant tuberculosis (MDR-TB) has begun. The study is comparing the safety and efficacy of a new MDR-TB drug, delamanid, with the decades-old TB drug isoniazid for preventing active MDR-TB disease in children, adolescents and adults at high risk who are exposed to adult household members with MDR-TB. Study participants are at high risk for MDR-TB because they either have latent TB infection, immune systems suppressed by HIV or other factors, or are younger than age 5 years and therefore have a weak immune system.
Uganda launches scale-up plan for TB preventive treatment (post)
Kampala, 4th July 2019: The Minister of Health, Dr Jane Ruth Aceng, launched a 100-Day Accelerated Scale-up plan for Tuberculosis Preventive Treatment (TPT) targeting over 300 000 People Living with HIV and AIDS (PLHIV) in Uganda. The government will also provide TPT to all children aged 12 months or more living with HIV as well as HIV-negative infants and children aged 5 years or below who are household contacts of patients with pulmonary Tuberculosis. As part of the scale-up plan, Government will provide TPT at 1 947 Antiretroviral therapy (ART) sites across the country.
High price delays introduction of new TB prevention therapy (post)
Despite being an ancient disease, tuberculosis (TB) remains the world’s leading infectious disease killer from a single infectious agent. For decades effective preventive therapy has existed, but has not been widely used. Recent optimism about a shorter and safer form of prevention therapy has been dampened because of its high price. While price negotiations continue behind closed doors, Spotlight asks when this new therapy will become available in South Africa.
Materials for IAS TB/HIV 2019 Symposium now available online (post)
The materials for IAS TB/HIV 2019 Symposium are now available online at the meeting website. These include the presentation slides, videos and some photos. Also the Call to action for a coordinated HIV and TB response to reach 6 million people living with HIV with tuberculosis preventive treatment can be found there.
A simple regimen can prevent TB. Why aren’t more people on it? (post)
Two antibiotics, taken for a month, can stop a leading killer. But “when it’s for TB, people just sort of shrug.”
In women with HIV, TB preventive therapy poses greater risk in pregnancy than postpartum (post)
October 2, 2019: Study results published today help clarify how to safely prevent tuberculosis (TB) in women living with HIV who are pregnant or have recently given birth, are taking antiretroviral therapy, and live where TB is highly prevalent.
How a new TB drug could stop one of the world’s deadliest diseases (post)
Tuberculosis struck 10 million people worldwide in 2017, killing 1.6 million of them – a toll greater than that of HIV, malaria, measles and Ebola combined. TB is the leading infectious killer around the globe; nearly 1.8 billion people are carrying the bacterium that causes the disease.
50th Union World Conference on Lung Health: Socioeconomic support improves TB prevention (post)
HYDERABAD, INDIA – Accelerating efforts to prevent tuberculosis wherever it is treated has been the rallying cry in Hyderabad during this conference. One study shows that providing financial incentives plus social support not only improves TB treatment completion but increases TB screening and preventative therapy uptake among household members of TB patients.
Page 5 of 18 · Total posts: 0
←First 4 5 6 Last→